Voyager Therapeutics, Inc. (VYGR) Operating cash flow 2016–2025
Voyager Therapeutics, Inc. (VYGR) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$132.5MFY2025 · since FY2016: -$42.5M → -$132.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$132.5M | -765.2% |
| FY2024 | -$15.3M | -119.6% |
| FY2023 | $77.9M | +722.9% |
| FY2022 | -$12.5M | +76.6% |
| FY2021 | -$53.5M | +44.7% |
| FY2020 | -$96.7M | -298.7% |
| FY2019 | $48.7M | +406.3% |
| FY2018 | -$15.9M | +74.1% |
| FY2017 | -$61.4M | -44.4% |
| FY2016 | -$42.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice